IIM
CALT

Ironwood Investment Management’s Calliditas Therapeutics AB American Depositary Shares CALT Stock Holding History

Ironwood Investment Management’s Portfolio CALT Stock Details CALT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-25,627
Closed -$999K – 176
2024
Q2 		$999K Buy
25,627
+116
+0.5% +$3.19K 0.53% 59
2024
Q1 		$536K Buy
25,511
+76
+0.3% +$1.69K 0.26% 97
2023
Q4 		$655K Sell
25,435
-1,253
-5% -$23.5K 0.34% 80
2023
Q3 		$487K Sell
26,688
-526
-2% -$9.1K 0.3% 89
2023
Q2 		$431K Sell
27,214
-581
-2% -$12.3K 0.25% 102
2023
Q1 		$666K Buy
27,795
+1,486
+6% +$29.7K 0.42% 78
2022
Q4 		$447K Sell
26,309
-2,433
-8% -$39.2K 0.29% 104
2022
Q3 		$436K Sell
28,742
-21
-0.1% -$366 0.3% 105
2022
Q2 		$511K Buy
28,763
+1
+0% +$17 0.34% 98
2022
Q1 		$551K Buy
28,762
+1,495
+5% +$30K 0.3% 110
2021
Q4 		$675K Sell
27,267
-569
-2% -$11.4K 0.33% 100
2021
Q3 		$602K Buy
27,836
+11,946
+75% +$328K 0.31% 105
2021
Q2 		$468K Buy
+15,890
New +$455K 0.24% 122

Other funds holding CALT

CGH
Crossmark Global Holdings Houston, Texas $7.71B AUM 37.66% 1-Year Est. Return
AP
Advisors Preferred Rockville, Maryland $679M AUM 22.19% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return
MTIC
Missouri Trust & Investment Company Springfield, Missouri $341M AUM 17.31% 1-Year Est. Return

Ironwood Investment Management's CALT Position: Q3 2024 in Review

Ironwood Investment Management sold out of Calliditas Therapeutics AB American Depositary Shares (CALT) in Q3 2024, closing a stake of 25,627 shares — an estimated $999K sold.

Ironwood Investment Management first reported a position in CALT in Q2 2021 and held it in 13 quarters. The position peaked at $999K in Q2 2024. 5 funds tracked by Wall St. Rank hold CALT as of Q3 2024.

  • Ironwood Investment Management reported no remaining Calliditas Therapeutics AB American Depositary Shares position as of Q3 2024 after selling out during the quarter.
  • Ironwood Investment Management sold 25,627 Calliditas Therapeutics AB American Depositary Shares shares in Q3 2024, an estimated $999K.
  • Ironwood Investment Management first reported a position in Calliditas Therapeutics AB American Depositary Shares in Q2 2021 and held it in 13 quarters.
  • Ironwood Investment Management's Calliditas Therapeutics AB American Depositary Shares position peaked at $999K in Q2 2024.
  • 5 funds tracked by Wall St. Rank held Calliditas Therapeutics AB American Depositary Shares as of Q3 2024.

Based on Ironwood Investment Management's 13F filing for Q3 2024, filed 14 Nov 2024.